Sunday, July 12, 2020
wellness India Expo
Home Tags NPPA

Tag: NPPA

NPPA says its actions reduced prices of N-95 masks by 47%,...

As per the National Pharmaceutical Pricing Authority (NPPA), its advisory and subsequent actions have led to the reduction of prices of N-95 mask prices significantly up to 47% by manufacturers and importers, increasing their availability and affordability..........

AiMeD welcomes govt’s schemes to promote domestic manufacturing of medical devices...

Mr Rajiv Nath, Forum Coordinator, AIMED applauded the government and thanked the Prime Minister during a video conference on behalf of the Indian Medical Device Industry....................

COVID-19: India has enough stocks of APIs & formulations, says govt

While the NPPA has denied any shortage of APIs and formulations, it has also not received any reference from pharma associations regarding steep increase in price of medicines due to outbreak of COVID-19 in China................

NPPA’s green signal to bioresorbable stent by Meril Life Sciences for...

An extensively researched innovation, MeRes100 BRS is backed by 3-year efficacy and safety clinical trial data, has received 8 patents worldwide, CE mark approval and a DCGI granted 122E new drug approval that attests to its efficacy and safety for the indicated use.....................

22 drugs in the market without approval, govt sends notices to...

The NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs. 5.56 crore has been recovered and demand notices amounting to Rs. 89.31 crore are under litigation....................

MTaI welcomes stent price hike, calls it necessary for quality healthcare

As per Medical Technology Association of India, there is a need to increase the prices of regulated medical devices by 11-16% to cushion the impact of high inflation and depreciation in the value of rupee vis-à-vis US dollar and Euro...............

Significant reduction in cancer drug prices due to trade margin capping

The National Pharmaceutical Pricing Authority, in its meeting on 26th February, 2019, invoked extraordinary powers in public interest, under Para 19 of the Drugs (Prices Control) Order, 2013 to bring 42 non-scheduled anti-cancer drugs under price control...…………..

Fixing medicine prices saved ₹11,462 crore for patients: Govt

As per the union minister, Mr Mansukh L. Mandaviya, the ceiling prices of 856 medicines fixed by the National Pharmaceutical Pricing Authority (NPPA), resulted in a saving of Rs 11,462 crore for patients. He ruled out any shortage of coronary stents due to price fixation...…………...

AiMeD terms demand of global MedTech companies on pricing as misleading

As per the Association of Indian Medical Device Industry, if trade margins are not rationalized including the importers margin, the consumers will suffer and if MRP is increased then also the consumers will suffer as the MRP is already excessively high...………..

AdvaMed disappointed over NPPA’s move to extend price-cap on knee implants...

The leading association of global medical technology companies has expressed its concern over NPPA not accepting the industry's demand for a 10 percent minimum increase in prices of knee implants despite the depreciation of rupee in recent times and increase in local operational costs